General experimental
All chemicals, unless specifically mentioned, were obtained from Sigma-Aldrich or Acros Organics. Solvents were purchased from Fischer Scientific. EDC·HCl, N-hydroxymaleimide and 4-(p-iodophenyl) butyric acid were purchased from Sigma Aldrich. The parent ODN sequences 1, 3 as well as precursor ODNs (p2, p2m, and p4) were synthesized using standard automated solid phase synthesis at the Keck Foundation Biotechnology Laboratory at Yale University. All phosphoramidites needed to prepare these ODNs, including fluorescein modifications (Fluorescein-dT Phosphoramidite) and synthetic handles/spacer groups (ThiolModifier C6 S-S, 3'-PT-Amino-Modifier C6 CPG and 3'-(6-FAM) CPG) were purchased from Glen Research. DCs 2 and 2m were synthesized as shown in Figure 
Preparation of DCs 2 and 2m
Figure SI 1. Synthetic scheme for DC 2.
As illustrated in Figure SI 1, ODN p2 was first treated with 50μL 100 mM DTT (in 60 mM NaHCO 3 aqueous solution, pH 8.5) at room temperature for 30 min to cleave the S-S bond and generate the free thiol functional group. After cleavage, the reaction was purified by G-25 spin column. This purification step was repeated three times. After which, a 50 μL solution containing 5 mg of N-hydroxymaleimide in 0.5 M MOPS buffer (3-morpholinopropanesulfonic acid) was added to the solution containing ODN p2a. After agitating for 30 min, the reaction was desalted by G-25 filtration and purified by reversephase HPLC. To link 4-(p-iodophenyl) butyric acid with NHS-tethered DC 2', 2.7 mg of 4-(piodophenyl) butyric acid was mixed with 2 mg of EDC·HCl in 100 μL DMF. After 5 min, 50 μL of this reaction mixture was added to 50 μL ODN DC 2' in 100 mM MES buffer (2-(Nmorpholino)ethanesulfonic acid), pH 6.0. The reaction was agitated for 30 min and desalted by G-25 column three times to remove unreacted small molecules. The resultant DC 2 was characterized by MALDI-TOF.
The same synthetic route as mentioned above was applied to prepare DC 2m, using p2m (below) as the precursor sequence. As illustrated in Figure SI 2, 2.7 mg of 4-(p-iodophenyl) butyric acid was mixed with 2 mg of EDC·HCl and 1.2 mg NHS in 100 μL DMF. After 2 hours, 50 μL of this reaction mixture was added to 50 μL ODN p4 in 60 mM NaHCO 3 buffer, pH 8.5. The reaction was agitated overnight and desalted by G-25 column, followed by HPLC purification.
The same synthetic route as mentioned above was applied to prepare DC 5, using p5 (below)
as the precursor sequence.
Ligand migration reaction via the formation of DC duplex 1:2
1.2 equivalent of DC 2 was added to 1 mL aqueous solution (50 mM MOPS and 10 mM Mg(OAc) 2 , pH 7.5) containing 1 μM DC 1 at 25 °C. The reaction was agitated for 30 min and then heated to 80 °C for 5 min. Note: the same conditions were used when attempting to react DC 2m and DC 1.
DC 1':2' disassembly and hydrolysis by DNase I
A) DC 1':2' Disassembly. Duplex DC 1':2' (1 μM in 200 μL PBS buffer, 137 mM NaCl, 2.7 mM KCl, pH 7.4) was incubated with 10 equivalents of ODN 3 at 90 °C for 2 min and then allowed to cool down to room temperature.
B) Nuclease hydrolysis. For the DNase I induced hydrolysis reaction, 10 μM of purified DC 1' was incubated with 4 units of DNase I in 100 μL 1X reaction buffer (10 mM TrisHCl, 2.5 mM MgCl 2 ,0.5 mM CaCl 2, pH 7.6) for 4 hours.
See Figure SI 12 for PAGE evidence for DNase I induced hydrolysis.
RP-HPLC
RP-HPLC purification of ODNs was carried out using a Varian Prostar HPLC system, equipped with an Agilent 100 Å 5 μm PLRP-S reverse phase column. The column was maintained at 65 °C for all runs. The flow rate was set at 1 mL/min. A gradient composed of two solvents (Solvent A is 0.1 M TEAA in 5% acetonitrile and solvent B is 100% acetonitrile) was used. UV absorption was monitored at 260 nm and 490 nm respectively. corresponding to DC 1'. While the reaction of DC 1 with DC 2m still shows intact reactant DC 1. Note: for these traces, the HPLC detector wavelength was set to 260 nm.
MALDI-TOF characterization of DCs
MALDI-TOF mass spectroscopy was performed on a Bruker Daltonics Autoflex III in a linear negative mode. The ODN samples were prepared using a 9:1:1 matrix of 2',4',6'-trihydroxyacetophenone monohydrate (THAP) (20mg/mL in 1:1 acetonitrile/water), ammonium citrate (50mg/mL in water, 1% TFA), and ODNs in H 2 O. Experimental parameters are shown in Table SI 
PAGE studies

A) Mobility shift assays
Non-denaturing polyacrylamide gel (15%) electrophoresis (PAGE) studies were performed using a BioRad mini protean tetra cell that is equipped with BioRad PowerPac HC. For the gel shown in Figure 2 μmole of DC 1 was introduced. The loading buffer was 1× TBE, the loading solution of each sample also contained 13.3% glycerol. The running buffer was 1× TBE buffer at 150 V, and the gel was run for 20 min. The gel was subsequently imaged on a Sony DSC-WX1 digital camera upon excitation with a hand held short wavelength UV-lamp.
B) DNase I degradation assay
To confirm the hydrolysis of DC 1' by DNase I, a PAGE study ( Figure SI 12 ) was carried out (under the same PAGE conditions mentioned above). This control shows that binding to HSA is weak and there is no saturation even at high HSA concentration. This result shows that the simple association of a duplex that projects both binding ligands (wherein the ip head-group is non-transferrable) is not as effective as the covalently fastened bidentate duplex 1':2'. Thus, the exact projection of the ip and fl head-groups is important for high-affinity HSA binding.
Hydrolysis of duplex 1:5, red circle (in an identical manner shown in SI-8 for duplex 1':2') further decreases the binding to HSA. Note that some binding is observed by the fl containing ODN fragments of DC 1 at high HSA concentrations. This likely means that the small fragments of DC 1 have a slightly better affinity for HSA versus the larger non-hydrolyzed DC 1 (Figure 2 , main text).
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